Research Paper Volume 16, Issue 3 pp 2457—2474

MRPS23 is a novel prognostic biomarker and promotes glioma progression


Figure 10. Nomogram and calibration curve for predicting the probability of 1-, 3-, and 5-years OS for glioma patients. (AC) A nomogram integrates MRPS23 and other prognostic factors in glioma from TCGA data. (DF) The calibration curve of the nomogram.